Silver Sulfadiazene (Watson Laboratories, Inc.)
Welcome to the PulseAid listing for the Silver Sulfadiazene drug offered from Watson Laboratories, Inc.. This Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Watson Laboratories, Inc. |
NON-PROPRIETARY NAME: | Silver Sulfadiazine |
SUBSTANCE NAME: | SILVER SULFADIAZINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1982-02-25 |
END MARKETING DATE: | 0000-00-00 |
Silver Sulfadiazene HUMAN PRESCRIPTION DRUG Details:
Item Description | Silver Sulfadiazene from Watson Laboratories, Inc. |
LABELER NAME: | Watson Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(g/1000g) |
START MARKETING DATE: | 1982-02-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-0810_476ce2f8-e0a4-4b1c-bda8-21e7998b8dc2 |
PRODUCT NDC: | 0591-0810 |
APPLICATION NUMBER: | NDA018578 |
Other SILVER SULFADIAZINE Pharmaceutical Manufacturers / Labelers: